Induction agents, sedatives and benzodiazepines
The GABA-A receptor and the sites at which sedatives act, the pharmacology of propofol, thiopentone, ketamine, etomidate and midazolam, the kinetic ideas that matter for a single dose and for an infusion, the cardiorespiratory consequences of induction, and the principles of antagonism.
By the end of this page you should be able to
- Describe the GABA-A receptor and how benzodiazepines, barbiturates and propofol modulate it differently.
- Explain why a single dose of a lipophilic induction agent is brief, and what context-sensitive half-time means.
- Compare propofol, thiopentone, ketamine, etomidate and midazolam in mechanism, onset, haemodynamic effect and adverse effects.
- Explain the mechanisms of peri-induction hypotension and of the rise in intracranial pressure during intubation.
- Describe the pharmacology of flumazenil and the principles and hazards of antagonism.
The receptor
Most sedatives work on the GABA-A receptor, a pentameric ligand-gated chloride channel. When GABA binds, the channel opens, chloride enters, the neurone hyperpolarises and becomes less excitable. Different drugs bind different sites on the same channel, which is why their effects add together.
Benzodiazepines bind at the interface of the alpha and gamma subunits and increase the frequency of channel opening. They are positive allosteric modulators: they need GABA to be present and cannot open the channel alone, so they have a ceiling and a relatively wide margin when used by themselves. Barbiturates bind elsewhere and increase the duration of opening, and at high concentration open the channel directly, so they have no ceiling. Propofol enhances GABA-A currents at its own site and has additional effects on other channels. Volatile agents and alcohol act at this channel too.
Ketamine is the exception: it is a non-competitive NMDA receptor antagonist, which is why its clinical profile differs so much from the rest.
Subunit composition explains why the clinical effects can be partly separated: alpha-1 containing receptors mediate sedation and amnesia, alpha-2 anxiolysis and muscle relaxation, and alpha-5 some memory effects. Chronic exposure produces tolerance through receptor uncoupling and subunit changes, and abrupt withdrawal leaves an unopposed excitatory state, which is why benzodiazepine and alcohol withdrawal cause seizures.
Kinetic ideas that matter
- Onset depends on getting into the brain: high lipid solubility, a largely unionised fraction at physiological pH, and a high cerebral blood flow give an onset within one circulation time. Reduced cardiac output slows arm to brain time, so the drug appears to take longer to act, and then has a greater effect because the same amount reaches a smaller volume.
- Offset after a single dose is by redistribution, not elimination. The drug leaves the brain as the plasma concentration falls while it is taken up by muscle and then fat; this is why a single dose of thiopentone or propofol wears off in minutes despite a much longer elimination half-life.
- Context-sensitive half-time is the time for the plasma concentration to halve after stopping an infusion, and it lengthens with the duration of the infusion as the peripheral compartments fill. It is short for propofol and very long for thiopentone, which is why propofol can be infused and thiopentone cannot.
- Protein binding and free fraction: these drugs are highly protein bound, so hypoalbuminaemia, uraemia and acidosis raise the free fraction and the effect of a given amount.
- The patient changes the dose needed far more than the drug does. In shock, the circulating volume is small, the sympathetic tone that is maintaining pressure is removed by the drug, and the required amount falls steeply; in the elderly, brain sensitivity is greater and clearance lower. For quantities and regimens, use the Australian Medicines Handbook or your local guideline.
The agents
- Propofol: a phenol in a lipid emulsion. Fast, smooth onset and offset with antiemetic and anticonvulsant properties, and it lowers cerebral metabolic rate, blood flow and intracranial pressure. The trade-off is dose-dependent vasodilatation, negative inotropy and loss of baroreflex response, so it is the least forgiving agent in a shocked patient; it also abolishes airway reflexes and respiratory drive readily. Pain on injection, involuntary movements, bradycardia, and (with prolonged high-dose infusion) propofol-related infusion syndrome with acidosis, rhabdomyolysis and cardiac failure. The emulsion supports bacterial growth and provides a lipid load.
- Thiopentone: a thiobarbiturate, highly protein bound, with rapid onset and redistribution offset. It is the most effective at reducing cerebral metabolic rate and raised intracranial pressure and is a potent anticonvulsant. Drawbacks are venodilatation with myocardial depression, histamine release and bronchospasm, severe tissue injury if extravasated or given intra-arterially, accumulation with repeated use, and precipitation of attacks in acute porphyria.
- Ketamine: dissociative anaesthesia with analgesia and preserved respiratory drive and airway reflexes. Indirectly sympathomimetic through catecholamine reuptake inhibition, so pressure and rate usually rise, which is why it is favoured in haemodynamic instability; but it is a direct negative inotrope, so pressure can fall in the catecholamine-depleted patient. A bronchodilator. Causes hypersalivation, emergence phenomena, nystagmus and a transient rise in intraocular pressure; the old teaching that it must be avoided in head injury has been revised, since it does not raise intracranial pressure when ventilation is controlled.
- Etomidate: a carboxylated imidazole with the most haemodynamic stability of the group, because it has little effect on vascular tone or contractility. It also lowers cerebral metabolic rate. The problem is reversible inhibition of 11-beta-hydroxylase, which suppresses adrenal cortisol synthesis after even a single dose; this is why its use in sepsis is contested. Also myoclonus, pain on injection and a high incidence of nausea.
- Midazolam: a water-soluble benzodiazepine that becomes lipid soluble at physiological pH, giving good brain penetration. Sedation, anxiolysis, anterograde amnesia, anticonvulsant and muscle relaxant effects, with a shorter half-life than diazepam and hepatic metabolism to an active metabolite that accumulates in renal impairment. It is a poor sole induction agent (slow and unreliable) but a good sedative and anticonvulsant, and it is markedly synergistic with opioids: the combination causes far more respiratory depression and hypotension than either alone.
- Other sedatives worth knowing by mechanism: dexmedetomidine, a central alpha-2 agonist giving sedation with little respiratory depression but bradycardia and hypotension; diazepam, long-acting with active metabolites; lorazepam, intermediate with no active metabolite and a long duration of clinical effect because of slow receptor dissociation; and chloral and antihistamines, whose sedation is not reversible.
Induction physiology and antagonism
Peri-induction hypotension has several mechanisms acting at once: removal of the sympathetic tone that was maintaining pressure in a compensated patient, direct vasodilatation and negative inotropy, loss of the baroreflex, and the start of positive pressure ventilation, which raises intrathoracic pressure and reduces venous return. In a patient who is already vasoconstricted and underfilled, each of these is amplified. The pharmacological answers are to resuscitate first where possible, to reduce the quantity given, to choose the agent that disturbs haemodynamics least, and to have a vasopressor prepared before induction rather than after the pressure falls.
Intracranial pressure rises with laryngoscopy and with coughing or straining; the aim of a neuroprotective induction is to prevent that surge while maintaining cerebral perfusion pressure, which is mean arterial pressure minus intracranial pressure. Hypotension is therefore as harmful as the pressure surge, and both must be avoided.
Flumazenil is a competitive antagonist at the benzodiazepine site. Like naloxone it acts quickly and has a shorter duration than the agonists it reverses, so re-sedation is expected and observation is timed from the last dose. Its hazards follow directly from the receptor pharmacology: in a patient who is dependent on benzodiazepines, or who has co-ingested a proconvulsant, removing GABA-A enhancement can precipitate seizures that are then difficult to treat because the usual drug has been blocked. For these reasons it is used selectively, most defensibly in iatrogenic over-sedation, and never as a routine diagnostic agent in the undifferentiated unconscious patient. There is no antagonist for propofol, thiopentone, ketamine or the volatile agents: their offset depends on redistribution and clearance, so supportive care is the treatment.
Making the answer flow
- Start with the channel and the three modulatory patterns (frequency, duration, direct opening); the ceiling effect of benzodiazepines then follows logically.
- Separate offset by redistribution from offset by elimination, and use context-sensitive half-time when asked about infusions.
- Compare agents in a fixed order: mechanism, onset and offset, cardiovascular effect, cerebral effect, specific adverse effects.
- For any induction in a shocked patient, give the four mechanisms of hypotension before naming a drug.
Where marks are lost
- Saying benzodiazepines open the chloride channel directly; they modulate it and need GABA.
- Explaining the brief effect of a single induction dose by a short elimination half-life.
- Calling etomidate haemodynamically neutral without mentioning adrenal suppression.
- Saying ketamine always raises blood pressure; it is a direct negative inotrope.
- Treating flumazenil as a routine antidote in an unknown overdose.
Where this meets intensive care
- Midazolam infusions accumulate in renal failure (active glucuronide metabolite) and with prolonged use as peripheral compartments fill; long context-sensitive half-times delay waking.
- Dexmedetomidine is an alpha-2 agonist giving rousable sedation without respiratory depression; bradycardia and hypotension are its common limits.
Viva questions
Answer each one aloud, as you would to an examiner, before you open the model points.
- 1.
Describe the GABA-A receptor and how sedatives act on it.
Show answer
- Pentameric ligand-gated chloride channel; opening hyperpolarises the neurone.
- Benzodiazepines bind the alpha and gamma interface and increase frequency of opening; require GABA, so there is a ceiling.
- Barbiturates increase duration of opening and can open the channel directly at high concentration, so no ceiling.
- Propofol, volatile agents and alcohol act at this channel too, so effects are additive.
- Subunit composition separates sedation, anxiolysis and amnesia; chronic use gives tolerance and a withdrawal state.
- 2.
Why does a single dose of propofol or thiopentone wear off in minutes?
Show answer
- Offset is by redistribution from brain to muscle and fat as the plasma concentration falls.
- Elimination half-life is much longer than the clinical effect of a single dose.
- Repeated doses saturate peripheral compartments and prolong the effect, markedly so for thiopentone.
- Context-sensitive half-time describes this and is why propofol, not thiopentone, is used by infusion.
- 3.
Compare propofol and ketamine for induction in a shocked patient.
Show answer
- Propofol: dose-dependent vasodilatation, negative inotropy, blunted baroreflex; profound hypotension in hypovolaemia.
- Ketamine: indirect sympathomimetic, usually maintains pressure, preserves respiratory drive and is a bronchodilator.
- Ketamine is a direct negative inotrope, so it can cause hypotension when catecholamines are depleted.
- Whichever is chosen, reduce the quantity, resuscitate first and have a vasopressor ready.
- 4.
What are the problems with etomidate?
Show answer
- Reversible inhibition of 11-beta-hydroxylase, suppressing cortisol synthesis after even a single dose.
- Contested use in sepsis because of that adrenal suppression.
- Myoclonus, pain on injection, high incidence of nausea and vomiting.
- Offset against the best haemodynamic stability of the group and a useful fall in cerebral metabolic rate.
- 5.
Why does blood pressure fall after induction and intubation, and how would you prevent it?
Show answer
- Loss of compensatory sympathetic tone; direct vasodilatation and negative inotropy; blunted baroreflex.
- Positive pressure ventilation raises intrathoracic pressure and reduces venous return.
- Prevent by resuscitating first, reducing the quantity of induction agent, choosing a more stable agent, and preparing a vasopressor beforehand.
- Anticipate worse effects in the elderly, the hypovolaemic and those with poor ventricular function.
- 6.
Describe the pharmacology of midazolam.
Show answer
- Water soluble at acid pH, lipid soluble at physiological pH, so rapid brain entry.
- Sedation, anxiolysis, anterograde amnesia, anticonvulsant and muscle relaxant effects.
- Hepatic metabolism with an active metabolite that accumulates in renal impairment; shorter half-life than diazepam.
- Marked synergy with opioids for respiratory depression and hypotension; tolerance and withdrawal with prolonged use.
- 7.
What is flumazenil and when is it unsafe?
Show answer
- Competitive antagonist at the benzodiazepine site of the GABA-A receptor; rapid onset, short duration.
- Re-sedation is expected because it is shorter acting than most agonists; observe from the last dose.
- Unsafe in chronic benzodiazepine dependence and in mixed overdose with a proconvulsant, because it can precipitate seizures that are then hard to treat.
- Most defensible for iatrogenic over-sedation; not a diagnostic agent in the undifferentiated unconscious patient.
- 8.
Which induction agents affect the brain usefully, and how?
Show answer
- Thiopentone and propofol reduce cerebral metabolic rate, cerebral blood flow and intracranial pressure, and are anticonvulsant.
- Etomidate also lowers cerebral metabolic rate with better haemodynamic stability.
- Ketamine does not raise intracranial pressure when ventilation is controlled, and helps maintain cerebral perfusion pressure.
- Cerebral perfusion pressure is mean arterial pressure minus intracranial pressure, so hypotension is as harmful as a pressure surge.
Practise this week
- Physiology Bench: move the graphs yourself
- First Part MCQs: pharmacology
- First Part SAQs, marked part by part
- First Part cross-table vivas
- Viva Examiner: practise answering aloud
Week 10 in the other subjects
- Physiology: Haemodynamics and the microcirculation
- Measurement: Ultrasound and Doppler
Not affiliated with the CICM. Notes are a revision aid, not a substitute for the curriculum or for clinical guidelines.